ENVB news & sentiment — Enveric Biosciences, Inc.

MAY 15·GuruFocusMed

Enveric (ENVB) Secures $13.9 Million in Private Placement Fundin

Enveric Biosciences Inc. (NASDAQ: ENVB) has successfully raised up to $13.9 million through a private placement, with an initial $5 million received upon closing. This funding, along with an additional $1.5 million from warrant exercises, will primarily support the preclinical development of its lead product candidate, EB-003, and facilitate the submission of an Investigational New Drug application. Despite a low GF Score™ of 28, indicating potential profitability challenges, the company boasts strong financial strength.

MAY 12·TradingKey

TradingKey

This page on TradingKey provides real-time and historical financial data for Enveric Biosciences Inc (ENVB), including its current stock price, market cap, and after-hours trading information. It also offers sections for financials, discussions, and analysis, inviting users to log in and comment. The platform highlights its features like "One powerful score" for smarter investment decisions and provides various tools and educational resources.

APR 24·Benzinga

What's Going On With Enveric Biosciences Stock On Friday?

Enveric Biosciences (NASDAQ: ENVB) stock surged nearly 30% after the FDA outlined steps to accelerate the development of serotonin-2A agonists and psychedelic-based therapies for mental health disorders. The FDA cleared the first U.S. trial for an ibogaine derivative to treat alcohol use disorder and will issue national priority vouchers to companies studying psychedelic compounds. This proactive stance follows a White House directive and focuses on fast-tracking promising treatments, especially those with Breakthrough Therapy designation.

$ENVB

Enveric (ENVB) Secures $13.9 Million in Private Placement Fundin

TradingKey

What's Going On With Enveric Biosciences Stock On Friday?

News on $ENVB